FDA: Xeljanz, Xeljanz XR (tofacitinib) related to increased risk of blood clots and death - NorthcentralPa.com

FDA: Xeljanz, Xeljanz XR (tofacitinib) related to increased risk of blood clots and death  NorthcentralPa.com

The FDA has approved new warnings about an increased risk of blood clots and of death with the 10 mg twice daily dose of Xeljanz, Xeljanz XR (tofacitinib), ...



Comments

Popular posts from this blog

Fibromyalgia — Latest Stories — Pain News Network

Chronic Lyme arthritis: A mystery solved?

Epstein-Barr virus and autoimmune diseases